RIGEL PHARMACEUTICALS INC Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Rigel Pharmaceuticals Inc quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q3 2024.
  • Rigel Pharmaceuticals Inc Other Assets, Noncurrent for the quarter ending September 30, 2024 was $4.76M, a 3.94% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.76M -$195K -3.94% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $4.74M +$4.19M +775% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $4.32M +$3.78M +697% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $3.06M +$2.42M +377% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $4.96M +$4.47M +924% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $541K +$138K +34.2% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $542K +$78K +16.8% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $640K -$334K -34.3% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $484K -$451K -48.2% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $403K -$437K -52% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $464K -$354K -43.3% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $974K +$150K +18.2% Dec 31, 2021 10-K 2023-03-07
Q3 2021 $935K +$115K +14% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $840K +$187K +28.6% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $818K +$157K +23.8% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $824K +$128K +18.4% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $820K +$125K +18% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $653K -$60K -8.42% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $661K -$68K -9.33% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $696K -$39K -5.31% Dec 31, 2019 10-K 2021-03-02
Q3 2019 $695K +$43K +6.6% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $713K +$35K +5.16% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $729K -$25K -3.32% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $735K -$68K -8.47% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $652K -$118K -15.3% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $678K -$26K -3.69% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $754K +$24K +3.29% Mar 31, 2018 10-Q 2018-05-01
Q4 2017 $803K +$39K +5.11% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $770K -$30K -3.75% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $704K -$138K -16.4% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 $730K -$334K -31.4% Mar 31, 2017 10-Q 2017-05-02
Q4 2016 $764K -$346K -31.2% Dec 31, 2016 10-K 2018-03-06
Q3 2016 $800K -$373K -31.8% Sep 30, 2016 10-Q 2016-11-01
Q2 2016 $842K -$179K -17.5% Jun 30, 2016 10-Q 2016-08-02
Q1 2016 $1.06M +$3K +0.28% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 $1.11M +$21K +1.93% Dec 31, 2015 10-K 2017-03-07
Q3 2015 $1.17M -$241K -17% Sep 30, 2015 10-Q 2015-11-03
Q2 2015 $1.02M -$440K -30.1% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 $1.06M -$423K -28.5% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $1.09M -$439K -28.7% Dec 31, 2014 10-K 2016-03-08
Q3 2014 $1.41M -$172K -10.8% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 $1.46M -$183K -11.1% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 $1.48M -$217K -12.8% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 $1.53M -$231K -13.1% Dec 31, 2013 10-K 2015-03-03
Q3 2013 $1.59M -$240K -13.1% Sep 30, 2013 10-Q 2013-11-05
Q2 2013 $1.64M -$231K -12.3% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $1.7M -$231K -12% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 $1.76M -$232K -11.7% Dec 31, 2012 10-K 2014-03-04
Q3 2012 $1.83M -$224K -10.9% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $1.88M -$255K -12% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $1.93M Mar 31, 2012 10-Q 2012-05-01
Q4 2011 $1.99M -$244K -10.9% Dec 31, 2011 10-K 2013-03-05
Q3 2011 $2.05M Sep 30, 2011 10-Q 2011-11-01
Q2 2011 $2.13M Jun 30, 2011 10-Q 2011-08-02
Q4 2010 $2.24M Dec 31, 2010 10-K 2012-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.